Eslicarbazepine is an anti-epileptic medication available commercially as eslicarbazepine acetate.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aripiprazole | The metabolism of Aripiprazole can be increased when combined with Eslicarbazepine. |
| Aripiprazole lauroxil | The metabolism of Aripiprazole lauroxil can be increased when combined with Eslicarbazepine. |
| Cilostazol | The serum concentration of Cilostazol can be increased when it is combined with Eslicarbazepine. |
| Buprenorphine | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Hydrocodone | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Magnesium sulfate | The therapeutic efficacy of Eslicarbazepine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Eslicarbazepine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Mirtazapine | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Orphenadrine | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Pramipexole | Eslicarbazepine may increase the sedative activities of Pramipexole. |
| Ropinirole | Eslicarbazepine may increase the sedative activities of Ropinirole. |
| Rotigotine | Eslicarbazepine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Eslicarbazepine. |
| Sodium oxybate | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Thalidomide | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Mefloquine | The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Mefloquine. |
| Mianserin | The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Mianserin. |
| Orlistat | Orlistat can cause a decrease in the absorption of Eslicarbazepine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Topotecan | Eslicarbazepine may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Eslicarbazepine. |
| Ifosfamide | The metabolism of Ifosfamide can be increased when combined with Eslicarbazepine. |
| Perampanel | The metabolism of Perampanel can be increased when combined with Eslicarbazepine. |
| Warfarin | The metabolism of Warfarin can be increased when combined with Eslicarbazepine. |
| Acenocoumarol | The metabolism of Acenocoumarol can be increased when combined with Eslicarbazepine. |
| (R)-warfarin | The metabolism of (R)-warfarin can be increased when combined with Eslicarbazepine. |
| (S)-Warfarin | The metabolism of (S)-Warfarin can be increased when combined with Eslicarbazepine. |
| R,S-Warfarin alcohol | The metabolism of R,S-Warfarin alcohol can be increased when combined with Eslicarbazepine. |
| S,R-Warfarin alcohol | The metabolism of S,R-Warfarin alcohol can be increased when combined with Eslicarbazepine. |
| Rifampin | The metabolism of Eslicarbazepine can be increased when combined with Rifampicin. |
| Nelfinavir | The metabolism of Eslicarbazepine can be increased when combined with Nelfinavir. |
| Zidovudine | The metabolism of Eslicarbazepine can be increased when combined with Zidovudine. |
| Ritonavir | The metabolism of Eslicarbazepine can be increased when combined with Ritonavir. |
| Lamotrigine | The metabolism of Eslicarbazepine can be increased when combined with Lamotrigine. |
| Efavirenz | The metabolism of Eslicarbazepine can be increased when combined with Efavirenz. |
| Testosterone propionate | The metabolism of Eslicarbazepine can be increased when combined with Testosterone propionate. |
| Tipranavir | The metabolism of Eslicarbazepine can be increased when combined with Tipranavir. |
| Tetracosactide | The risk or severity of liver damage can be increased when Tetracosactide is combined with Eslicarbazepine. |
| Carbamazepine | The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eslicarbazepine. |
| Oxcarbazepine | The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Eslicarbazepine. |
| Phenytoin | The serum concentration of Eslicarbazepine can be decreased when it is combined with Phenytoin. |
| Mephenytoin | The serum concentration of Eslicarbazepine can be decreased when it is combined with Mephenytoin. |
| Primidone | The serum concentration of Eslicarbazepine can be decreased when it is combined with Primidone. |
| Phenobarbital | The serum concentration of Eslicarbazepine can be decreased when it is combined with Phenobarbital. |
| Fosphenytoin | The serum concentration of Eslicarbazepine can be decreased when it is combined with Fosphenytoin. |
| Ethanol | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Fluvoxamine. |
| Duloxetine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Dapoxetine. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Alaproclate. |
| Erlotinib | The serum concentration of Erlotinib can be decreased when it is combined with Eslicarbazepine. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Eslicarbazepine. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Eslicarbazepine. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Eslicarbazepine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Eslicarbazepine is combined with Cocaine. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Eslicarbazepine. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Eslicarbazepine. |
| Pizotifen | The risk or severity of CNS depression can be increased when Pizotifen is combined with Eslicarbazepine. |
| Dosulepin | The risk or severity of CNS depression can be increased when Dosulepin is combined with Eslicarbazepine. |
| Quetiapine | The risk or severity of CNS depression can be increased when Quetiapine is combined with Eslicarbazepine. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Eslicarbazepine. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Eslicarbazepine. |
| Terfenadine | The metabolism of Terfenadine can be increased when combined with Eslicarbazepine. |
| Clozapine | The serum concentration of Clozapine can be decreased when it is combined with Eslicarbazepine. |
| Zopiclone | The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Eslicarbazepine. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Eslicarbazepine. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Eslicarbazepine. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Eslicarbazepine. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Eslicarbazepine. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Eslicarbazepine. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Eslicarbazepine. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Eslicarbazepine. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Eslicarbazepine. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Eslicarbazepine. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Eslicarbazepine. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Eslicarbazepine. |